Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gian Maria Rossolini

Showing results (31-40 of 452) with videos related to

Pageof 46
Sort By:
Antimicrobial Agents and Chemotherapy|May 26, 2006
Postgenomic scan of metallo-beta-lactamase homologues in rhizobacteria: identification and characterization of BJP-1, a subclass B3 ortholog from Bradyrhizobium japonicumMagdalena Stoczko, Jean-Marie Frère, Gian Maria Rossolini, et al.
Infection and Drug Resistance|July 8, 2021
An Evidence-Based Multidisciplinary Approach Focused at Creating Algorithms for Targeted Therapy of BSIs, cUTIs, and cIAIs Caused by <i>Enterobacterales</i> in Critically Ill Adult PatientsMilo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
AcrAB Efflux System: Expression and Contribution to Fluoroquinolone Resistance in Klebsiella sppAnnarita Mazzariol, Jessica Zuliani, Giuseppe Cornaglia, et al.
Diagnostic Microbiology and Infectious Disease|December 25, 2021
Evaluation of Revogene® Carba C assay for the rapid detection of carbapenemase genes in gram-negative pathogensEleonora Riccobono, Chiara Cervini, Fabio Morecchiato, et al.
Microorganisms|February 25, 2023
Targeted Therapy of Severe Infections Caused by <i>Staphylococcus aureus</i> in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World EvidenceMilo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Antibiotics (Basel, Switzerland)|December 11, 2019
The Urgent Need for Novel Antimicrobial Agents and Strategies to Fight Antibiotic ResistanceMarco Maria D'Andrea, Maurizio Fraziano, Maria Cristina Thaller, et al.
Expert Review of Anti-Infective Therapy|September 7, 2021
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patientsMilo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
International Journal of Molecular Sciences|August 14, 2025
Antimicrobial Photodynamic Activity of the Zn(II) Phthalocyanine RLP068/Cl Versus Antimicrobial-Resistant Priority PathogensIlaria Baccani, Sara Cuffari, Francesco Giuliani, et al.
Diagnostic Microbiology and Infectious Disease|August 28, 2024
Evaluation of the Vitek® Reveal™ system for rapid antimicrobial susceptibility testing of Gram-negative pathogens, including ESBL, CRE and CRAB, from positive blood culturesAlberto Antonelli, Sara Cuffari, Benedetta Casciato, et al.
Microbiology (Reading, England)|September 29, 2001
The Chryseobacterium meningosepticum PafA enzyme: prototype of a new enzyme family of prokaryotic phosphate-irrepressible alkaline phosphatases?Francesca Berlutti, Claudio Passariello, Laura Selan, et al.
Pageof 46

Showing results (31-40 of 452) with videos related to

Sort By:
Pageof 46
Antimicrobial Agents and Chemotherapy|May 26, 2006
Postgenomic scan of metallo-beta-lactamase homologues in rhizobacteria: identification and characterization of BJP-1, a subclass B3 ortholog from Bradyrhizobium japonicumMagdalena Stoczko, Jean-Marie Frère, Gian Maria Rossolini, et al.
Infection and Drug Resistance|July 8, 2021
An Evidence-Based Multidisciplinary Approach Focused at Creating Algorithms for Targeted Therapy of BSIs, cUTIs, and cIAIs Caused by <i>Enterobacterales</i> in Critically Ill Adult PatientsMilo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
AcrAB Efflux System: Expression and Contribution to Fluoroquinolone Resistance in Klebsiella sppAnnarita Mazzariol, Jessica Zuliani, Giuseppe Cornaglia, et al.
Diagnostic Microbiology and Infectious Disease|December 25, 2021
Evaluation of Revogene® Carba C assay for the rapid detection of carbapenemase genes in gram-negative pathogensEleonora Riccobono, Chiara Cervini, Fabio Morecchiato, et al.
Microorganisms|February 25, 2023
Targeted Therapy of Severe Infections Caused by <i>Staphylococcus aureus</i> in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World EvidenceMilo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Antibiotics (Basel, Switzerland)|December 11, 2019
The Urgent Need for Novel Antimicrobial Agents and Strategies to Fight Antibiotic ResistanceMarco Maria D'Andrea, Maurizio Fraziano, Maria Cristina Thaller, et al.
Expert Review of Anti-Infective Therapy|September 7, 2021
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patientsMilo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
International Journal of Molecular Sciences|August 14, 2025
Antimicrobial Photodynamic Activity of the Zn(II) Phthalocyanine RLP068/Cl Versus Antimicrobial-Resistant Priority PathogensIlaria Baccani, Sara Cuffari, Francesco Giuliani, et al.
Diagnostic Microbiology and Infectious Disease|August 28, 2024
Evaluation of the Vitek® Reveal™ system for rapid antimicrobial susceptibility testing of Gram-negative pathogens, including ESBL, CRE and CRAB, from positive blood culturesAlberto Antonelli, Sara Cuffari, Benedetta Casciato, et al.
Microbiology (Reading, England)|September 29, 2001
The Chryseobacterium meningosepticum PafA enzyme: prototype of a new enzyme family of prokaryotic phosphate-irrepressible alkaline phosphatases?Francesca Berlutti, Claudio Passariello, Laura Selan, et al.
Pageof 46